🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the relative bioavailability of sing...
Status
Terminated
Location
Celerion
Start Date
2017-02-20
Trial ID
NCT03059303
This study will evaluate a new ophthalmic formulation of cyclosporine (Rest...
Status
Terminated
Location
Sall Research Medical Center
Start Date
2014-04-29
Trial ID
NCT02013791
Treatments Being Tested
The study will try, in 2 separate parts, each using 12 research subjects, t...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-01
Trial ID
NCT00838058
Treatments Being Tested
The purpose of this study is to compare the pharmacokinetics (PK) profiles ...
Status
Completed
Location
Parexel International
Start Date
2012-06
Trial ID
NCT01686217
Treatments Being Tested
evaluate the efficacy of the intravenous formulation of fentanyl citrate ad...
Status
Unknown
Location
Alexandria university
Start Date
2021-06-01
Trial ID
NCT04991298
Treatments Being Tested
This is a Phase 1, open-label, dose-escalation and expansion study evaluati...
Status
Terminated
Location
Exelixis Clinical Site #4
Start Date
2021-02-10
Trial ID
NCT04726332
Treatments Being Tested
TAPISTRY is a Phase II, global, multicenter, open-label, multi-cohort study...
Status
Active Not Recruiting
Location
Western Regional Medical Center at Cancer Treatment Centers of America
Start Date
2021-01-18
Trial ID
NCT04589845
To determine the safety and tolerability of single oral doses of HPN-100 as...
Status
Completed
Location
Medical Sanitary Division #2
Start Date
2005-03
Trial ID
NCT00977600
The purpose of the study is to assess the safety, tolerability, and IOP eff...
Status
Completed
Location
Sall Research Medical Center
Start Date
2015-12-29
Trial ID
NCT02622334
Treatments Being Tested
This study has 2 parts. Part 1 will evaluate the safety and IOP effects of ...
Status
Completed
Location
Multiple Locations
Start Date
2010-06
Trial ID
NCT01110499